Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myeloid Leukaemias (AML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04951778
What this trial is testing

Study to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Celgene 56
Testing effectiveness (Phase 2)Study completedNCT01786343
What this trial is testing

Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 74
Testing effectiveness (Phase 2)Looking for participantsNCT05322850
What this trial is testing

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMixed Phenotype Acute Leukemia+4 more
University of Florida 40
Testing effectiveness (Phase 2)Ended earlyNCT00871689
What this trial is testing

Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 2
Very early researchStudy completedNCT04484532
What this trial is testing

Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Roswell Park Cancer Institute 130
Early research (Phase 1)UnknownNCT04886206
What this trial is testing

Injection of Lymphocytes From Haplo-identical Donor Following Chemotherapy in Patients With High-risk Acute Myeloblastic Leukemia Not Eligible for an Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia (AML)
Nantes University Hospital 12
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07604233
What this trial is testing

Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML

Who this might be right for
Myeloid Leukemia
M.D. Anderson Cancer Center 30
Large-scale testing (Phase 3)UnknownNCT02979548
What this trial is testing

Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy

Who this might be right for
Chemotherapy Induced VomitingAcute Myeloid Leukemia
Dr Atul Sharma 116
Testing effectiveness (Phase 2)Looking for participantsNCT05682755
What this trial is testing

Chidamide Prevents Recurrence of High-risk AML After Allo-HSCT

Who this might be right for
Leukemia, Myeloid, Acute
Sichuan University 77
Testing effectiveness (Phase 2)Looking for participantsNCT05736978
What this trial is testing

Adaptive Treatment for Acute Myeloid Leukemia Based on D14 MRD Results

Who this might be right for
AMLMRD
Shanghai Tong Ren Hospital 58
Testing effectiveness (Phase 2)WithdrawnNCT02856178
What this trial is testing

Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients

Who this might be right for
Pulmonary Aspergillosis - InvasiveAcute Myeloid Leukemia
F2G Ltd
Testing effectiveness (Phase 2)Active Not RecruitingNCT06429098
What this trial is testing

Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 40
Early research (Phase 1)Ended earlyNCT02875093
What this trial is testing

Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Polaris Group 23
Testing effectiveness (Phase 2)UnknownNCT01520558
What this trial is testing

CNDO-109-AANK for AML in First Complete Remission (CR1)

Who this might be right for
Acute Myeloid Leukemia
Coronado Biosciences, Inc. 12
Early research (Phase 1)Active Not RecruitingNCT03709758
What this trial is testing

Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML

Who this might be right for
Acute Myeloid Leukemia
Dana-Farber Cancer Institute 50
Early research (Phase 1)Active Not RecruitingNCT06325748
What this trial is testing

SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

Who this might be right for
AML/MDSCD33 Expressing Hematological MalignanciesFLT3 Expressing Hematological Malignancies
Senti Biosciences 21
Not applicableLooking for participantsNCT06452732
What this trial is testing

Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Peking University People's Hospital 283
Early research (Phase 1)Study completedNCT04500587
What this trial is testing

Phase 1 First in Human Study of ZN-d5 as a Single Agent

Who this might be right for
Acute Myeloid LeukemiaNon Hodgkin Lymphoma
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. 39
Early research (Phase 1)Study completedNCT05048498
What this trial is testing

Pharmacokinetics, Tolerability and Safety of NEX-18a

Who this might be right for
Myelodysplastic Syndromes (MDS)Chronic Myelomonocytic Leukemia (CMML)Acute Myeloid Leukemia (AML)
Nanexa AB 2
Next Page